معرفی
Kevin Nash, PhD, is a Clinical Associate Professor of Pathology at the Keck School of Medicine, University of Southern California. His research focuses on mycobacterial pathogenesis, antimicrobial resistance mechanisms, and clinical pathology. He has contributed significantly to understanding drug resistance in non-tuberculous mycobacteria (NTM) and the molecular basis of macrolide resistance in various Mycobacterium species. His work also extends to ophthalmological research, including neuroinflammation in diabetic retinopathy and therapeutic delivery systems in retinal diseases.
Dr. Nash's publications span over two decades, with a strong emphasis on microbiology and infectious diseases. Recent works explore Fractalkine's role in retinal inflammation and CAF-secreted annexin A1's impact on prostate cancer stem cells. Earlier contributions include groundbreaking studies on erm gene-mediated resistance in Mycobacterium abscessus and intrinsic resistance mechanisms in rapidly growing mycobacteria.
His educational contributions include a collaborative analysis of medical student education programs across 145 U.S. and Canadian schools. He maintains active collaborations in clinical microbiology, antimicrobial therapy, and translational research bridging basic science and clinical practice.
Though no specific grants or awards are listed, his extensive publication record underscores sustained research excellence in infectious diseases and clinical pathology. He is affiliated with the Keck School of Medicine's Department of Pathology and contributes to teaching and patient care in clinical microbiology.
